Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation　– The Kumamoto Intervention Conference Study (KICS) Registry –

Masanobu Ishii(Kumamoto Health Science University), Ichiro Kajiwara, Toshiyuki Matsumura(Japan Organization of Occupational Health and Safety), Hisao Ogawa(Kumamoto University Hospital), Kunihiko Matsui(Kumamoto University), Ryusuke Tsunoda(Japanese Red Cross Kumamoto Hospital), Hideki Shimomura(Fukuoka Tokushukai Hospital), Natsuki Nakamura(Beppu Medical Center), Tomonori Akasaka, Nobuyasu Yamamoto(Miyazaki Prefectural Hospital), Naritsugu Sakaino, Yuji Miyao(National Cerebral and Cardiovascular Center), Seiji Hokimoto(Kumamoto University), Koichi Kaikita(Kumamoto University), Kazuteru Fujimoto(Kumamoto Medical Center), Kōichi Nakao(Kanazawa Seiryo University), Yasuhiro Morikami(Kumamoto City Hospital), Hideki Oka, Shuichi Oshima(Kumamoto Chuo Hospital), Toyoki Hirose, Shunichi Koide(Kumamoto Medical Center)
Circulation Journal
January 1, 2015
10.1253/circj.cj-14-0789
Cited by 22

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848